This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
deep [2022/09/02 11:03] bas [Data availability] |
deep [2025/02/05 14:49] (current) |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== DEEP/DAG1 ====== | ====== DEEP/DAG1 ====== | ||
- | Lifelines-DEEP, also known as DAG1, is one of [[start|Lifelines]]' [[additional assessments]] performed in collaboration with the UMCG [[https://www.systemsgenetics.nl/|department of genetics]] (see also: [[DAG2]] and [[DAG3]]). DAG is the abbreviation of DArmGezondheid, or "Gastrointestinal health" in Dutch, a research project in which the microbiome is analysed in faecal samples.\\ | + | Lifelines-DEEP, also known as DAG1, is one of [[start|Lifelines]]' [[additional assessments]] performed in collaboration with the UMCG [[https://www.systemsgenetics.nl/|department of genetics]] (see also: [[DAG2]], [[DAG3]], [[DAG4]] and [[DAG5]]). DAG is the abbreviation of DArmGezondheid, or "Gastrointestinal health" in Dutch, a research project in which the microbiome is analysed in faecal samples.\\ |
The primary goal of the Lifelines-DEEP project is to get insight in the relations between [[https://en.wikipedia.org/wiki/Genome|genome]], [[https://en.wikipedia.org/wiki/epigenome|epigenome]], [[https://en.wikipedia.org/wiki/Transcriptome|transcriptome]], [[https://en.wikipedia.org/wiki/microbiome|microbiome]], [[https://en.wikipedia.org/wiki/metabolome|metabolome]], and other biological and phenotypic parameters. Lifelines-DEEP is an example of a ‘next- generation’ population cohort study—in which multiple molecular data levels are combined with observational research methods ((Tigchelaar EF et al. (2015) Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5(8): e006772)) | The primary goal of the Lifelines-DEEP project is to get insight in the relations between [[https://en.wikipedia.org/wiki/Genome|genome]], [[https://en.wikipedia.org/wiki/epigenome|epigenome]], [[https://en.wikipedia.org/wiki/Transcriptome|transcriptome]], [[https://en.wikipedia.org/wiki/microbiome|microbiome]], [[https://en.wikipedia.org/wiki/metabolome|metabolome]], and other biological and phenotypic parameters. Lifelines-DEEP is an example of a ‘next- generation’ population cohort study—in which multiple molecular data levels are combined with observational research methods ((Tigchelaar EF et al. (2015) Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5(8): e006772)) | ||
===== Subcohort ===== | ===== Subcohort ===== | ||
- | From April to August 2013, all adult participants registered at the Lifelines location in Groningen were invited to participate in Lifelines-DEEP, in addition to the regular Lifelines programme. Inclusion stopped when the target group size of n=~1500 was reached. | + | From April 2012 to August 2013, all adult participants registered at the Lifelines location in Groningen were invited to participate in Lifelines-DEEP, in addition to the regular Lifelines programme. Inclusion stopped when the target group size of n=~1500 was reached. |
===== Protocol ===== | ===== Protocol ===== | ||
Line 25: | Line 25: | ||
| Metabolomics | +/- 1400 | Yes | | | Metabolomics | +/- 1400 | Yes | | ||
| Cytokines | +/- 1100 | Yes | | | Cytokines | +/- 1100 | Yes | | ||
- | | Proteomics | - | No | | + | | Proteomics | +/- 1100 | Yes | |
+ | | WES | +/- 1000 | Yes | | ||
*Raw data is available; the processed data is not available yet | *Raw data is available; the processed data is not available yet | ||